Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials

被引：640

作者：

Newlands, ES

Stevens, MFG

Wedge, SR

Wheelhouse, RT

Brock, C

机构：

[1] UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,CANC RES CAMPAIGN,EXPT CANC CHEMOTHERAPY RES GRP,NOTTINGHAM NG7 2RD,ENGLAND

[2] UNIV TEXAS,COLL PHARM,DRUGS DYNAM INST,AUSTIN,TX 78712

来源：

CANCER TREATMENT REVIEWS | 1997年 / 23卷 / 01期

关键词：

D O I：

10.1016/S0305-7372(97)90019-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：35 / 61

页数：27

共 106 条

[1] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER [J].

AALTONEN, LA ;

PELTOMAKI, P ;

LEACH, FS ;

SISTONEN, P ;

PYLKKANEN, L ;

MECKLIN, JP ;

JARVINEN, H ;

POWELL, SM ;

JEN, J ;

HAMILTON, SR ;

PETERSEN, GM ;

KINZLER, KW ;

VOGELSTEIN, B ;

DELACHAPELLE, A .

SCIENCE, 1993, 260 (5109) :812-816

[2] PHARMACOKINETICS OF THE C-13 LABELED ANTICANCER AGENT TEMOZOLOMIDE DETECTED IN-VIVO BY SELECTIVE CROSS-POLARIZATION TRANSFER [J].

ARTEMOV, D ;

BHUJWALLA, ZM ;

MAXWELL, RJ ;

GRIFFITHS, JR ;

JUDSON, IR ;

LEACH, MO ;

GLICKSON, JD .

MAGNETIC RESONANCE IN MEDICINE, 1995, 34 (03) :338-342

[3] DEPLETION OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE CORRELATES WITH POTENTIATION OF TEMOZOLOMIDE AND CCNU TOXICITY IN HUMAN TUMOR-CELLS [J].

BAER, JC ;

FREEMAN, AA ;

NEWLANDS, ES ;

WATSON, AJ ;

RAFFERTY, JA ;

MARGISON, GP .

BRITISH JOURNAL OF CANCER, 1993, 67 (06) :1299-1302

[4] ANTITUMOR IMIDAZOTETRAZINES .12. REACTIONS OF MITOZOLOMIDE AND ITS 3-ALKYL CONGENERS WITH OXYGEN, NITROGEN, HALOGEN, AND CARBON NUCLEOPHILES [J].

BAIG, GU ;

STEVENS, MFG .

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1987, (03) :665-670

[5] POSSIBLE ROLES OF BETA-ELIMINATION AND DELTA-ELIMINATION REACTIONS IN THE REPAIR OF DNA CONTAINING AP (APURINIC APYRIMIDINIC) SITES IN MAMMALIAN-CELLS [J].

BAILLY, V ;

VERLY, WG .

BIOCHEMICAL JOURNAL, 1988, 253 (02) :553-559

[6] A PHASE-II STUDY OF MITOZOLOMIDE IN METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE BLADDER [J].

BLACKLEDGE, G ;

ROBERTS, JT ;

KAYE, S ;

TAYLOR, R ;

WILLIAMS, J ;

DESTAVOLA, B ;

USCINSKA, B .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :391-392

[7] CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATIC MELANOMA [J].

BLEEHEN, NM ;

NEWLANDS, ES ;

LEE, SM ;

THATCHER, N ;

SELBY, P ;

CALVERT, AH ;

RUSTIN, GJS ;

BRAMPTON, M ;

STEVENS, MFG .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) :910-913

[8] POTENTIATION OF TEMOZOLOMIDE-INDUCED CYTOTOXICITY - A COMPARATIVE-STUDY OF THE BIOLOGICAL EFFECTS OF POLY(ADP-RIBOSE) POLYMERASE INHIBITORS [J].

BOULTON, S ;

PEMBERTON, LC ;

PORTEOUS, JK ;

CURTIN, NJ ;

GRIFFIN, RJ ;

GOLDING, BT ;

DURKACZ, BW .

BRITISH JOURNAL OF CANCER, 1995, 72 (04) :849-856

[9] REDUCTION OF THE TOXICITY AND MUTAGENICITY OF ALKYLATING-AGENTS IN MAMMALIAN-CELLS HARBORING THE ESCHERICHIA-COLI ALKYLTRANSFERASE GENE [J].

BRENNAND, J ;

MARGISON, GP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (17) :6292-6296

[10] PLASMA AND TISSUE DISPOSITION OF MITOZOLOMIDE IN MICE [J].

BRINDLEY, CJ ;

ANTONIW, P ;

NEWLANDS, ES .

BRITISH JOURNAL OF CANCER, 1986, 53 (01) :91-97

← 1 2 3 4 5 6 7 8 9 10 →